PAPER Altinoglu G, Adali T
SEARCH RESULTS
327 RESULTS
PAPER Zhang Y, Bander ED, Lee Y, Muoser C, Schaffer CB, Nishimura N
Microvessel occlusions alter amyloid-beta plaque morphology in a mouse model of Alzheimer's disease.
J Cereb Blood Flow Metab. 2019 Nov 19;:271678X19889092. PubMed: 31744388PAPER Chesneau S, Faucher C, Morin G, Le Dorze G
Evaluation of AID-COM, a communication-focused program for family carers of people with early-stage Alzheimer's disease: A pilot study (innovative practice).
Dementia (London). 2019 Nov 19;:1471301219887038. PubMed: 31744329PAPER Pecio Ł, Alilou M, Orhan IE, Eren G, Deniz FS, Stuppner H, Oleszek W
Yuccalechins A-C from the Yucca schidigera Roezl ex Ortgies Bark: Elucidation of the Relative and Absolute Configurations of Three New Spirobiflavonoids and Their Cholinesterase Inhibitory Activities.
Molecules. 2019 Nov 16;24(22) PubMed: 31744162PAPER Shimizu S, Takenoshita N, Inagawa Y, Tsugawa A, Hirose D, Kaneko Y, Ogawa Y, Serisawa S, Sakurai S, Hirao K, Kanetaka H, Kanbayashi T, Imanishi A, Sakurai H, Hanyu H
Positive Association Between Cognitive Function and Cerebrospinal Fluid Orexin A Levels in Alzheimer's Disease.
J Alzheimers Dis. 2020;73(1):117-123. PubMed: 31744010PAPER Yare K, Woodward M
Hormone Therapy and Effects on Sporadic Alzheimer's Disease in Postmenopausal Women: Importance of Nomenclature.
J Alzheimers Dis. 2020;73(1):23-37. PubMed: 31744009PAPER Cioffi F, Adam RH, Broersen K
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.
J Alzheimers Dis. 2019;72(4):981-1017. PubMed: 31744008PAPER Sawant N, Reddy PH
Role of Phosphorylated Tau and Glucose Synthase Kinase 3 Beta in Huntington's Disease Progression.
J Alzheimers Dis. 2019;72(s1):S177-S191. PubMed: 31744007PAPER Hegde V, Dhurandhar NV, Reddy PH
Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?
J Alzheimers Dis. 2019;72(s1):S71-S79. PubMed: 31744006PAPER Jia J, Ji Y, Feng T, Ye Q, Peng D, Kuang W, Ning Y, Liang Z, Fan D, Wei W, Li Y, Xiao S
Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease.
J Alzheimers Dis. 2019;72(4):1313-1322. PubMed: 31744005PAPER Defrancesco M, Marksteiner J, Kemmler G, Dal-Bianco P, Ransmayr G, Benke T, Mosbacher J, Höller Y, Schmidt R
Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).
J Alzheimers Dis. 2020;73(1):125-133. PubMed: 31744004PAPER Garcia-Segura ME, Fischer CE, Schweizer TA, Munoz DG
APOE ɛ4/ɛ4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer's Disease Pathological Load.
J Alzheimers Dis. 2019;72(4):1077-1087. PubMed: 31744003PAPER Parvand M, Rankin CH
Is There a Shared Etiology of Olfactory Impairments in Normal Aging and Neurodegenerative Disease?
J Alzheimers Dis. 2020;73(1):1-21. PubMed: 31744002PAPER Wang SY, Chen W, Xu W, Li JQ, Hou XH, Ou YN, Yu JT, Tan L
Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis.
J Alzheimers Dis. 2019;72(4):1353-1361. PubMed: 31744001PAPER Hays CC, Zlatar ZZ, Meloy MJ, Osuna J, Liu TT, Galasko DR, Wierenga CE
Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOEɛ4 Carriers.
J Alzheimers Dis. 2020;73(1):87-101. PubMed: 31743999Current Filters
- Date Range : Nov 2019 to Nov 2019 x